Topic:

Recent advances in HSCT for inborn errors of immunity – haploidentical transplantation

Description:

The webinar will cover various topics related to recent advances in HSCT for inborn errors of immunity – haploidentical transplantation.

After participating in the webinar, participants should be able to:
- Understand the updated transplant outcomes after a haploidentical donor transplant for inborn errors of immunity.
- Appreciate the multi-center transplant outcomes and recognize the potential pitfalls associated with in-vitro TCRαβ/CD19 depletion and in-vivo T-cell depletion with post-transplant cyclophosphamide for haploidentical donor transplant for inborn errors of immunity.
- Understand current single-center results of haploidentical transplant with post-transplant cyclophosphamide in inborn errors of immunity with a special focus on CGD.
- Explore the unmet needs in the field of haploidentical transplant for inborn errors of immunity.

Speakers:

• Moderator: Michael Albert 
  Head, Pediatric SCT program · Dr. von Hauner University Children’s Hospital, Munich, Germany

Michael Albert is the Head of the Pediatric stem cell transplantation unit at the Dr. von Hauner University Children’s Hospital, Munich (Director: C. Klein). Chairperson, Inborn Errors Working Party of ESID (since 2020). Secretary, Inborn Errors Working Party of EBMT (since 2017). PID stream lead and board member, European Reference Network Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (ERN RITA, since 2020).

• Su Han Lum (Speaker)
  Dr · Newcastle University/Great North Children’s Hospital

Dr Lum is a Senior Clinical Research Fellow in Paediatric Haematopoietic Stem Cell Transplantation at the University of Newcastle upon Tyne and Honorary Consultant for Northern Supra-Regional Bone Marrow Transplant Unit for Inborn Errors of Immunity at the Great North Children’s Hospital, Newcastle upon Tyne. Her research interests include personalized haematopoietic stem cell transplantation, graft manipulation, memory T cells and late effects.

• Benedicte Neven (Speaker)
  Professor · Necker Children’s hospital, Paris, France

Benedicte Neven is a professor of pediatric, working in the pediatric immunehematology Unit of Necker Children’s hospital in Paris where she coordinates the activity of bone marrow transplantation. Her clinical and research activities are dedicated to patients with primary immune deficiencies from diagnosis to therapy including targeted treatment when available, bone marrow transplantation, and cellular therapy. She is currently the chair of the IEWP of EBMT.

June 27, 2023 15:00 CEST in Amsterdam, Berlin, Rome, Stockholm, Vienna